it's called regeneron, and other things too, but i think this was the key, but they gave me regeneronlt good immediately. i felt as good three days ago as i do now. i've authorized it. and if you're in the hospital and you're feeling really bad, i think we're going to work it so that you get them, and you're going to get them free, and especially if you're a senior, we're going to get you in there quick. we have hundreds of thousands of doses that are just about ready. >> trump was probably down playing the severity of his condition when he said he wasn't feeling so hot. days earlier his doctors told reporters, he had a high fever, his oxygen levels twice dropped below normal. to balance back quickly in less than a week, it might say a lot about the medicine he received. he was treated with monoclonal antibody, and when his buddies got infected he made sure to share the treatment with them. secretary housing secretary ben carson said trump cleared him for regeneron which he says saved his life. former new jersey governor chris christie who said he was in intensive care for a week said

somehow neither the cdc nor the nih has gotten behind regeneron's terrific job i think this is total negligence by the u.s. government the governor of the besieged state of michigan gretchen widmer painted its praises in a speech yesterday, giving the stock new life cdc, nih, will you stop putting the hate on regeneron? medical stocks all rallied hard today. how hard even the beleaguered johnson & johnson managed to go up now the market didn't overlook the fact that we got some blowout retail sales numbers, allowing retailers to roar and because interest rates went down signaling lower infection, the secular growth stocks that we all know and love, twilio, okta, they just soar that's what happens when interest rates go down big on the other hand, the banks gave up the ghost, not because they put up bad numbers, but numbers are real good one, that one later, but because the smart money was betting that fed chief powell would have to raise rates to combat inflation. that's such a cliche and good news for the banks. but when you see bond yields plummeting, that suggests those rate hikes

regeneron is the best known.e and also it was the one given to president trump when he was diagnosed and went to walter reed. use this to treat people who have covid, at high risk of getting very sick from it. the infusion happens before you have to be hospitalized. it has to happen early in your infection. but today regeneron said they'll ask the fda if their treatment can be used at a broader time. basically, if it can be used to prevent treatment. according to phase three clivengal trial of people who were exposed to the virus, household exposure to the virus, taking this drug actually reduced the risk of getting covid, getting symptomatic infection by over 80%. the prospect that this could keep you from getting infected if you are exposed to somebody with covid could be another big, major use for these types of drugs. the other sort of exciting top line from this trial is that for the purposes of this trial, they didn't give this drug in an iv infusion. they simply gave it as an injection, as a shot, same way

regeneron is probably the best known of all these therapies, one because it's the easiest to pronounce. also because it's the one given to trump when he was diagnosed with covid-19 and he went to walter reed. again, he used this to treat people who had covid who are at high risk of getting very sick from it. the infusion happens before you have to be hospitalized. it has to happen early in your infection. but today they're gonna ask if the fda if their treatment can be used because if it can be used to prevent treatment. according to a phase three clinical trial to people who were exposed to the virus, taking regeneron and taking this drug actually reduce the risk of getting covid, getting symptomatic infection by over 80%. the prospect that this could keep you from getting infected if you're exposed could be there could be another major use for these types of drugs the other exciting top line for this trial is for the purposes of this trial, they didn't give this drug in an iv infusion. they simply gave it as an injection. as a shot, the same when you get a vaccine. this is a much eas

regeneron is a great product but can't work for free. one of my favorites reports on thursday morning, pen national gaming and like cannabis, gambling is a real run here. momentum has the partnership with bar stool brought in the gamblers i think they have we'll see, want to walk a tight rope thursday we'll hear from roku, peloton. they were fabulous lockdown stocks, weren't they amc is a terrific great reopening play i think roku and peloton can keep winning, right? but that doesn't mean they're stocks we have adjusted habits and we'll keep doing some of this stuff when the pandemic is over, but these two roku and peloton are two of the most expensive stocks in the entire market. so their winning might not translate into higher stock prices as for amc, it's got so much stock for sale that i don't think you can rally as the reopening will save the business amc is a meme stock like other things that is rallying now. who knows what the wacky self-des self-d self-described degeneretes will do on this one i call them that because they call t

regeneron is probably the best known of all these therapies, one because it's the easiest to pronounce. also because it's the one given to trump when he was diagnosed with covid-19 and he went to walter reed. again, he used this to treat people who had covid who are at high risk of getting very sick from it. the infusion happens before you have to be hospitalized. it has to happen early in your infection. but today they're gonna ask if the fda if their treatment can be used because if it can be used to prevent treatment. according to a phase three clinical trial to people who were exposed to the virus, taking regeneron and taking this drug actually reduce the risk of getting covid, getting symptomatic infection by over 80%. the prospect that this could keep you from getting infected if you're exposed could be there could be another major use for these types of drugs the other exciting top line for this trial is for the purposes of this trial, they didn't give this drug in an iv infusion. they simply gave it as an injection. as a shot, the same when you get a vaccine. this is a much eas

we have to have the regeneron.egeneron. the cdc and nih carl have been so bad on this regeneron cocktail that it is in warehouses this is the one former president trump took regeneron made it sound like it was bufferin or something. it is not. but they need it so badly in michigan and the nih and cdc seem he will bennett on making it difficult to get it doctors can't get it your doctor may not even be able to go this for you. >> that is only if you are sick in the first place. >> -- very sick? >> no i'm just saying it is not for -- >> if you have a family member you can take it. >> the conversation i'm having is this is not about people coming to the office sick. it is about when is everybody who is going to start coming back who's been fully vaccinated that's dominating organizations conversations i've had when this is where you work and i expect you here, or can i not do that because it is starting -- >> you and i have spoke on the ceos you know what the word is. >> yes. >> there are people who just say you know

regeneron has treatments roech has treatments they are not getting media attention.e best right now? >> the interesting thing is we deal with a lot of early companies. i can tell you for sure there are lots of capital going to early companies advancing promising treatments that are better than those available now. those that are available now are pretty good. the problem is, as you pointed out, they are not being used remdesivir, the anti-viral is used in 50% or 60% of people hospitalized in the country. use of remdesivir is modest outside the u.s. antibodies a catch-22 with the antibodies they are sitting in hospitals, but the indication is for pre-hospital patient if somebody shows up and says you want an anti-body. you are not sick enough to admit, so we cannot give you antibody some of the early stage companies, they are bringing forward antibodies to be given in the doctor's office or walk-in clinic it can be given with lower doses. that will make the big difference even the current antibodies need to be used much more broadly both pre-exposure and post-exposure

let me ask you about regeneron, i know lots of people who have gotten the infusion at this point. company phase 3 clinical trial that it reduced symptomatic, what is your thoughts on using regeneron as preventive? doctor: clearly have sean it's an effective product and the problem with regeneron problem even with people symptomatic is find them fast enough and link them which is iv infusion. this is great news that they have in t new data but we have to work on the concept of operations of finding people that were exposed quick enough that they can actually benefit from this and over time because vaccination rollout has gotten so much better it's going to have less and less of a role but important role to have when it can be used and when it can be used quickly and fast. maria: yeah, i know that's why you've got to get the antibodies infusion as soon as possible when you know that you are covid positive. dagen mcdowell, jump in here. dagen: dr. adalja i went through this when i tested positive in march for covid because i had a very low grade fever and i immediately based on the g

and don't miss the cnbc interview with the regeneron ceo.t have to choose. that's why insurers are going hybrid with ibm. with watson on a hybrid cloud they can use ai to help predict client needs and get the data they need to quickly design coverage for each one. businesses that want personalization and speed are going with a smarter hybrid cloud using the technology and expertise of ibm. nice bumping into you. i really hope that this vaccine can get me one step closer to him. to a huge wedding. to give high fives to our patients. to hug my students. with every vaccine, cvs is working to bring you one step closer to a better tomorrow. >>> welcome back to "squawk box. i'm dominic chu here with your "market minute." a few of the big things to watch this week. you've got a big week coming up with earnings, specifically with regard to the banks. the banks have been a massive outperformer in the market over the course of last six months. look at the financial sticker spdr has gained. up 17%, very respectable, but still, more than doubling in ter

regeneron pharmaceuticals has asked the u.s. food and drug administration to expand emergency use of its monoclonal antibody cocktail. regeneron says a clinical trial showed its drug reduced the risk of symptomatic infection by over 80% among people who lived in the same household as someone who tested positive for coronavirus. in immigration news, human rights defenders are condemning the biden administration's agreements with mexico, honduras, and guatemala to further militarize their borders and regions in an attempt to keep asylum seekers from reaching the united states. white house press secretary jen psaki said monday the objective is to make people's journey north and crossing through borders more difficult. erika guevara-rosas, amnesty international's americas director, denounced biden's move and said -- "instead of deploying more troops, governments in the region must respect and uphold people's rights to seek asylum and live in safety." to see our full interview with her, you can go to democracynow.org. the united nati

they used regeneron. an amazing -- an amazing drug.lue they just sort of caulk it onto your body. put the head back on doctors said to me, 'sir, we couldn't believe that the blade went through your skin toughest skin they've ever seen.' rich -- they said, 'like rich corinthian leather.' ricardo montalban. bad guy, mean guy. [ laughter ] nice -- nice to meet him." you guys, of course, trump is refusing to be one of his most loyal defenders now that gaetz is in legal trouble. haven't these guys learned anything trump will never return loyalty you show him, ever that's why he's never had a dog. if trump played fetch with a golden retriever, the first time he brought back the tennis ball, trump would present the dog with the bill so trump is dodging gaetz after gaetz spent years parading trump's most unhinged lies next thing you know, trump is going to start acting like he doesn't even know matt gaetz's name >> it was trump's fault. it is all ways trump's fault can it ever be like rick gaetz's fault? i mean - [ laughter ] it's always trump

offering to send michigan more testing supplies and more therapeutics the announcement comes at regenerongainst covid in households where somebody is infected meg tirrell covers science and medicine for us and is on the top story at the bottom of the hour meg, this new therapy can not only help treatment covid but help preventing it. >> yeah, shep, they ran this trial along with the national institutes of health people who lived with someone who tested positive for the virus within the previous four days, and what they foundi is that this antibody cocktail reduced the risk of them getting sick by 81%. so here's how the numbers broke down they enrolled about 1,500 people who lived with someone with covid. they found that 59 people got the placebo and got sick compared with 11 people who received the drug. they also found of those who got the medicine but still got covid, they recovered a lot faster now, this is the kind of medicine that doctors say could really help in a place like michigan seeing a surge of infection. >> it is a situation where you have lots of unvaccinated people and lot

regeneron antibody treatment actually reduces risk.

regeneron antibody treatment actually reduces risk. how that drug company is trying to expand access. u.s. cruise companies threatening to cruise over to another country if the u.s. doesn't let them operate here. i will talk to the mayor of miami on the impact. call it whatever you want. that is what democrats said about infrastructure. now they want to change the meaning of another issue. stay with us, hear about that later this hour. but first, the top story we're following today, president biden is just about to address the chip shortage with ceo's. he is going to be using this as on opportunity to tout his $2.25 trillion spending plan. fox business's blake burman is live from the white house with the very latest. reporter: david, yeah, we certainly do expect to hear to president biden shortly on that matter, tout the need for the $2.25 trillion american jobs plan as it relates to semiconductors or chips as we better know them because one of the parts of that plan is to invest in $50 billion in manufacturing, research and developmen

doctors can't prescribe it, many hospitals don't have it gretchen whitmer says this is the hope, regenerond think that stock should be much higher. >> jim, currently up about 3 1/2. what's up tonight? >> american eagle outfitters, never does tv, and yet they had what is by far the best number of any retailer. dr. michael mina, the foremost doctor in the world about self-testing and what we should be doing at home, and it's about time we forgot about that, it's crazy carl, we've got to keep the sick people from the workplace because the numbers are still gigantic every day covid. i want to talk to him right now. >> i can't wait to hear what aeo tells you too, jim, because it's been a week of news from l.b we had news on tapestry today, a new ceo. i wonder, are you feeling better about the mall or not? >> feeling great about the mall. teenagers love the mall. maybe they don't have anything else to do, but american eagle outfitters had the best number you have seen, and levis was great, denim is back they're cooped up, ready to roll >> certainly retail sales might indicate that is true. jim,

there is a lot of attention paid to them divesting their equity state in regeneron, the u.s. lot of this is waiting to see if there's any more clues on what they might do in terms of in organically adding assets to the pipeline. that is one of the reasons we are equal weight on the share. we think the m&a story will be very important to how this company proceeds in the next few years. we will want to have more clarity on what is going to happen. alix: can i talk glaxosmithkline. it is the first time they reported a quarter with allergy -- with elliott management. they doing enough to battle the activist? emily: we got that initial article reporting a couple of weeks ago. it has been very quiet since then. we are all waiting to see if we get clues into what they are gunning for at gsk outside of what was reported in the article. we do not have a lot of information. the ceo was asked, they would comment with regards to individual investors. they said they are very committed to the spin, that is one thing that has been discussed among investors, could they switch the consumer sp

welcome back big news in the ncontinued figh of covid and this has nothing to do with vaccines regenerone cdc if they can use the drug ace preventative treatment this request comes after a key phase three clinical trial which found the drug reduced symptomatic infections by 81%. that is great news good reminder that our treatments have gotten better over the last couple months. all this as america does break another vaccination record over the weekend. in all, more than 4.6 million people got their jabs. a new record and more than 500,000 more than the old record set one week ago >>> on deck, your morning rbi and the massive figure on just how much new money has come into global markets in the last couple of months trust me this one is going to get our eyes open. >>> and programming note tune in to our new "tech check." it launches today at 11:00 a.m. eastern time with a great guest lineup we're back after this. tner to help share the load. wealth is saving a little extra. worth is knowing it's never too late to start - or too early. ♪ ♪ wealth helps you retire. worth is knowing why. ♪ ♪

recommend it and because of that i can't do it but i have to tell you, look, it's an antibody, you want regenerondon't you make it so nobody gets a vaccine and nobody uses it when they go to the hospital and rain the impending doom. let's go to scott in rhode island, scott? >> caller: what's going on big boo-yah from rhode island. my stock is tmdx. >> you know what i happen to be very -- this is about end stage organ failure patients and transplant and i happen to know i'm doing a fundraiser for a charity that does this it very, very hard and i'm going to say it's not going to be -- i don't think it will be a profitable business any time soon. well, and that, ladies and gentlemen is the conclusion of the lightning round. >> announcer: the lightening round is sponsored by td ameritrade coming up, how did a lost watch fortify one of cramer's most reliable pieces of market wisdom find out when "mad money" returns. hinkorswim even better, we listen. like jack. he wanted a streamlined version he could access anywhere, no download necessary. and kim. she wanted to execute a pre-set trade strategy in se

regeneron is seeking u.s.ventive treatment after studies show the antibody therapy cut the risk of symptomatic infection in a household where at least one member had covid. johnson & johnson, though, is faced with a headwind just as it began delivering its single-dose vaccine to e.u. nations such as greece and italy today, the shot will be in short supply across the u.s. this week after millions of doses were recently ruined. let's get to grady trimble. he is at a mass vaccination site in kinly park, illinois. what are you seeing, and how's the flow there for availability? >> reporter: so this is actually the johnson & johnson side of the room, liz. they're also doing the moderna vaccine here, and as you can see on this side of the room, there are still people getting the jab from j&j with. that being said, they got a delivery on friday, but as of this week, on monday, and next week they're expecting exactly zero doses because of those production issues. and cities are plagued with that challenge all across th

we've got a slight move downward for most of these names, regeneron, bill idea sciences, amgen, theyo quickly check pfizer, move, yeah, slightly lower by two-thirds of a percent. moderna up 2.5%, j&j down a quarter of a percent. and, again, we want to make this clear, the moving up of the vaccine eligibility rate for all adults starting 16 -- i know 16-year-olds are not exactly adults, but 16 and over by two weeks. we'll be watching very closely how this affects the u.s. economy. we do understand that he will also say that 63 million americans have now received the shot, is that correct? 63 million or is it more than that? okay. 63 million according to the cdc. president biden has said he originally wanted 100 million in the first hundred days. he's moved that up to 200 million, and at the moment let's just check the markets. we've got the dow jones industrials down 130 points. we have crude oil moving higher. yesterday it got hit by about 3%, but it is moving slightly higher. let us turn to larry kudlow as we await the president and his announcements. clearly, you can imagine that m

it's regeneron -- >> time for the nih and cdc to get their act together and start pushing what the doctorm getting angry at them. they should be playing ball and helping people, not just throwing rocks at this, this is crazy. i need al in new jersey, al? >> caller: this is al. my stock is bumble, bmbl. >> i'm a believer in her and what she's doing and created the stock is down. brad in florida, brad? >> caller: jimmy chill just had a quick question. by the way, i hope the eagles draft jalen phillips you guys need pass rushers i had a quick question. >> all right. >> caller: these guys would be -- i had a quick question is it a buy investment banking. >> i like coin base and i like semi let's go to jason in new york. jason? >> caller: boo-yah, jim. this is jason out of long island quick shoutout to my beautiful girlfriend danielle. >> danielle, man >> caller: i bought a company i was on your show awhile back and had a big pull back. looking to see what you think of plug power. >> plug power had accounting issues and i'm still trying to get my arms around and having trouble doing that and i

vanessa: meanwhile, the drugmaker regeneron reported its antibody cocktail is 93% effective after oneeing administered. the company is seeking u.s. regulatory approval. president biden ramped up his push today for a $2.3 trillion jobs and infrastructure package. he met with bipartisan lawmakers and said he's open to compromise with republicans who've criticized the plan's spending and tax hikes. we'll dig deeper into the plan later in the program. president biden has also issued a raft of new nominations to top government jobs. the police chief of tucson, arizona, chris magnus, is the pick for commissioner of customs and border protection. former pentagon official christine wormuth will be the first woman tapped for secretary of the army. and anne milgram is being nominated to lead the drug enforcement administration. still to come on the "newshour," israel is suspected of destroying a power generator at a nuclear facility in iran. a new book exposes how the sackler family became a catalyst for the opioid crisis. congress returns to business with the president's infrastructure bill on

shattered matt hepburn's 60-day mark, including biotech company abcellera, working with eli lilly, and regenerondent trump. >> crowe: this is the new normal. it's going to be 60 days from here on out. >> whitaker: well, not quite yet. currently, antibodies are grown in a bio-reactor like this one at this defense department rapid response plant in florida. it'll take three weeks for this to produce 7,500 doses. >> crowe: and so a lot of scientists are trying to figure out, can this be done faster? >> whitaker: dr. crowe has successfully tested a faster way: r.n.a., the genetic tool darpa helped pioneer that was used to make the coronavirus vaccine in record time. in the next outbreak, r.n.a. would allow factories like this to churn out millions of doses a day. >> crowe: we would start from a blood sample from a survivor, and be done with all of this and be giving you an injection of the cure within the 60 days. >> whitaker: with their promise of speed, immediate protection, and a cure, dr. hepburn says r.n.a. antibodies could stop the next wuhan-like outbreak cold. >> hepburn: it's really beyond

. >> woodruff: meanwhile, the drugmaker regeneron reported its antibody cocktail is 72% effective againstnfections in the first week, and 93% after that. the company is seeking u.s. regulatory approval. in ukraine, president volodymyr zelenskyy's office complained today that russia is ignoring his request for talks with president vladimir putin. ukrainian officials now estimate russia has massed more than 40,000 troops along the frontier between the two countries, with another 40,000 in neighboring crimea. president biden ramped up his push today for a $2.3 trillion jobs and infrastructure package. he met with bipartisan lawmakers and said he's open to compromise with republicans who've criticized the plan's spending and tax hikes. >> i'm prepared to negotiate as to the extent of my infrastructure project as well as how we pay for it if we get a serious conversation about how to do that. i think everyone acknowledges we need a significant increase in infrastructure. >> woodruff: we'll go deeper into the politics and prospects of the plan, later in the program. the treasury department repo

regeneron pharmaceuticals announced today that it is asking the fda to expand the use of its treatment here in the u. s. the company says it's antibody therapy reduces the risk of covid-19 by more than 80% for general incited clinic. a results rather of a new clinical study involving more than 1500 patients. no one in the study was infected with the virus but lived in the same household with someone who recently tested positive person is dead and a police officer wounded after a shooting at a high school in knoxville, tennessee, and we're getting late word this evening that it was a student at the school who fired the shots. it happened this afternoon after police responded to a report of an armed person on the campus at austin, east magnet, high school. police say shots were fired after police approached the student. he was killed in the exchange of gunfire and a police officer was hit at least one time. his wound is not said to be life threatening. another person was detained for questioning. officials say the school building was secured and students were then released to their famil

other deposits suggesting it would be helpful for other monoclonal antibodies like regeneron to be sent here to michigan. i have reached out to doctors to see if they requested more of those and have not heard back yet. just before the wk they put in voluntary restrictions people don't eat indoors anymore and high school goes back to remote learning and sports take a pause but those were voluntary because remember the governor was stripped of her emergency powers for any statewide emergency orders to make them mandatory. doctors are very hesitant about these voluntary restrictions being effective because when you look at the date, steph, it's april 2021, but those hospitalizations rates we are seeing is the same as april 2020. there's a lot of concern and frustration from health care providers. >> maura, thank you. we have to dig deeper and find out what this means. let's bring in dr. roger besser, former acting director of the cdc and currently ceo of the robert fordham foundation. i have so many questions but i want to start with the white house telling michigan they will not send mor

i'm the beneficiary of the regeneron antibody treatment, which was great.herapeutics. i want to switch to another controversial subject. texas governor greg abbott just signing an executive order prohibiting vaccine passports in his state. made a statement saying, and i'm quoting here, government should not require any texan to show proof of vaccination and reveal private health information to just go about their daily lives. so, doctor, what do you make of this? a lot of people, i think, are justifiably worried about the state getting too much infgrlation about what goes on inside of us. >> yeah, i agree, david. i think that's an infringement on personal freedom. as much as i as a doctor would like to see everyone vaccinated, and i mean everyone, i still think that it's really an infringement to ask for a person who's getting on a subway train or on a plane, have is you been vaccinated, and if you don't have that passport, you're thrown off the plane. i think that's an infringement on personal freedom. wewe who have been vaccinated, those who have not are

lastly, antibodies are developed by regeneron. early data. a worldwide crisis and love to see a conversation with health regulatory bodies in india whether to potentially start to trial those therapies there and then vaccines that's the wave of the future for maybe a 2022 booster. there's phase one data that's compelling. potentially again. think outside the box here to what can we surge to the indian people quickly enough? we don't have this vaccines for india and the rest of the world. that's the bottom line by the enof 2021 and will continue to be a crisis. >> i hope your phone rings for more advice and i know they do watch you. thank you so much for spending sometime with us. claire is sticking around. >>> when we come back, as republicans beat themselves up for who can be most loyal to the former guy democrats are finding opportunities to expand the majority perhaps. e of doing what's right, not what's easy. so when a hailstorm hit, usaa reached out before he could even inspect the damage. that's how you do it right. usaa insurance is ma

not because there is a problem with the drug, but the nih stating the cocktails from regeneron be usedhe cocktail a little bit complicated important nonetheless. joe. >>> thanks, andrew pfizer's ceo the latest vaccine maker to say that regular shots will likely be needed to protect against the coronavirus. let's bring in dr. scott gottlieb a former fda commissioner and cnbc contributor and board member of pfizer we scour the headlines every day. i don't know, i have to say that there's a mixture of positive and really encouraging things along with things concerning, scott. i don't know i'm coming down on the side we will figure out a way, science, to maybe deal with this. here is what is in the paper 5,800 cases of cohorts that got the covid-19 infection although vaccinated by both shots that's out of 66 million that's what i figure you would say that is 90% efficacy looks like, right? >> yeah. a low percentage of people you know, obviously over a defined time period. covid is still circulated. you figure contacted people are coming in contact with the infection. it is good news. reass